These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8078202)

  • 21. [Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
    Iwabuchi S; Osada T; Takatori M; Yoshida H
    Nihon Rinsho; 1994 Jul; 52(7):1880-8. PubMed ID: 7521434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C.
    Hakozaki Y; Shirahama T; Katou M; Nakagawa K; Oba K; Mitamura K
    Am J Gastroenterol; 1995 Aug; 90(8):1246-9. PubMed ID: 7639224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis.
    Mochida S; Ohnishi K; Matsuo S; Kakihara K; Fujiwara K
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up evaluation in HCV chronic hepatitis treated with alpha-2b interferon. A comparison of two protocols.
    Budillon G; Cimino L; Del Vecchio Blanco C; Mazzacca G; Iaquinto G; D'Ascoli B; Lampasi F; Di Sapio M; Mattera D; Sapio D [corrected to Di Sapio M]
    Ital J Gastroenterol; 1994; 26(1):16-20. PubMed ID: 8025301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The breakthrough phenomenon during alpha-interferon therapy of chronic hepatitis C: incidence, management, and outcome.
    Lebovics E; Lantin J; Chaurushia G; Dworkin BM; Casellas A; Rosenthal WS
    Am J Gastroenterol; 1995 Jun; 90(6):951-4. PubMed ID: 7771428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
    Carreño V; Tapia L; Ryff JC; Quiroga JA; Castillo I
    J Med Virol; 1992 Jul; 37(3):215-9. PubMed ID: 1331310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial.
    Kiso S; Kawata S; Tamura S; Imai Y; Inui Y; Nagase T; Maeda Y; Yamasaki E; Tsushima H; Igura T; Himeno S; Seki K; Matsuzawa Y
    J Gastroenterol; 1997 Feb; 32(1):56-62. PubMed ID: 9058296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
    Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H
    Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF.
    Van Thiel DH; Faruki H; Friedlander L; Fagiuoli S; Caraceni P; Molloy PJ; Kania RJ; Wright HI
    Hepatogastroenterology; 1995; 42(6):907-12. PubMed ID: 8847044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C.
    Anderson FH; Zeng L; Yoshida EM; Rock NR
    Can J Gastroenterol; 1997; 11(4):294-7. PubMed ID: 9218853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term therapeutic efficacy of interferon for patients with chronic hepatitis C.
    Takeda T; Kuroki T; Fukuda K; Yabusako T; Nishiguchi S; Nakajima S; Shiomi S; Seki S; Monna T; Sakurai M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():104-8. PubMed ID: 8359619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, controlled trial of human lymphoblastoid interferon in patients with compensated type C cirrhosis.
    Saito T; Shinzawa H; Kuboki M; Ishibashi M; Toda H; Okuyama Y; Nakamura T; Yamada N; Wakabayashi H; Togashi H
    Am J Gastroenterol; 1994 May; 89(5):681-6. PubMed ID: 8172137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of non-A, non-B hepatitis with glycyrrhizin].
    Ohta W; Iwamura K
    Nihon Rinsho; 1988 Dec; 46(12):2681-8. PubMed ID: 3149342
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interferon therapy of compensated type C cirrhosis].
    Saito T; Shinzawa H; Takahashi T
    Nihon Rinsho; 1994 Jul; 52(7):1875-9. PubMed ID: 8078203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2',5' Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
    Gastroenterol Jpn; 1991 Oct; 26(5):603-10. PubMed ID: 1752391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.
    Maeda T; Onishi S; Miura T; Iwamura S; Tomita A; Saibara T; Yamamoto Y
    Dig Dis Sci; 1995 Jun; 40(6):1226-30. PubMed ID: 7781437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
    De Bac C; Grimaldi F; Clementi C; Duca F; Livoli D; Taliani G
    Gut; 1993; 34(2 Suppl):S135. PubMed ID: 8314480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of chronic HCV infection and efficacy of interferon in chronic hepatitis C patients with a history of blood transfusion. The Study Group for Treatment of Hepatitis in the Kyushu Area.
    Sata M; Kage M; Inoue O; Sakaguchi S; Yano M; Kashiwagi S; Sakai T; Okumura M; Tanikawa K
    Kansenshogaku Zasshi; 1997 May; 71(5):405-11. PubMed ID: 9209120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of intramuscular human interferon-beta vs interferon-alpha 2b for the treatment of chronic hepatitis C.
    Pérez R; Pravia R; Artímez ML; Giganto F; Rodríguez M; Lombraña JL; Rodrigo L
    J Viral Hepat; 1995; 2(2):103-6. PubMed ID: 7493297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.